FDA Inspection 1176430 — Lexamed, Ltd

Lexamed, Ltd — FEI 1525897

The FDA completed an inspection of Lexamed, Ltd on Aug 4, 2022 in Toledo, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 4, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Toledo, OH (United States)

Citations

IDCFRDescription
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
180921 CFR 211.160(a)Following/documenting laboratory controls